Results 191 to 200 of about 17,041,985 (363)
Polymyxins as inhibitors of polyclonal B-cell activators in murine lymphocyte cultures [PDF]
Thomas Butler +3 more
openalex +1 more source
A practical guide to hydrogels for cell culture
S. Caliari, J. Burdick
semanticscholar +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
T Cell Growth Factor from Human Splenic Cell Cultures: Conditions for Its Production, and Its Utilization for Maintenance of Cytotoxic T Cell Lines [PDF]
Yuetsu Tanaka +2 more
openalex +1 more source
Differential phenotype and behavior in culture of CD34 positive cells from peripheral blood and adipose tissue [PDF]
Harald Froehlich +2 more
openalex +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Electron Microscopy of Virus Particles in Cell Cultures Inoculated with Passage Fluid From Human Laukaemic Bone-marrow [PDF]
D. R. Inman, D. A. Woods, G Negroni
openalex +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source

